Palm Beach Labs Review: One NAD+ Vial, Two Storefronts, Two Prices

Palm Beach Labs sells a compounded NAD+ injection from two different websites, and the two websites disagree about what it costs.

On the company's main site the product card reads "NAD+ Injectable — Starting Price At — $169 / mo", with an asterisk after it. On its separate sales site, a second storefront under a different web address, the same injection is $169 for the first month, with $240 struck through beside it, above a line that reads: "Renews at standard rate of $240/mo."¹

Featured partner

CoreAge Rx

From $93/mo

Check availabilityRead our review

Affiliate link. We may earn a commission at no extra cost to you.

Affiliate partner

System Labs

Compounded NAD+ & longevity telehealth

See System Labs↗

The prices were rechecked on both rendered storefronts on October 15, 2026.⁸

Same company. We checked that carefully, because a similar name is not an identity: the second site publishes the same phone number and the same contact address as the first, and its footer sends you to the first site's terms of service, privacy policy, telehealth consent and contact page. It has no legal pages of its own. Both sell the same injection and name the same medical advisor. This is one operator with two front doors.

The asterisk that goes nowhere

Follow the asterisk on the main site and there is nothing at the end of it. It appears eight times on that page — once beside every product's price — and the page has no footnote explaining it anywhere. So a reader is told $169 a month, marked with a symbol that promises a qualification, and never given the qualification.

The qualification is on the company's other website: $169 is a first month, and the standing rate is $240. That is a 42 percent increase from month two onward, and it is disclosed — just not on the page that most people will read.

What makes this matter is the sentence sitting in the main site's own frequently-asked questions, just below the $169 card. Asked whether it takes insurance, the company answers: "No insurance is needed, we offer transparent out-of-pocket prices. What you see is what you pay!"

What you see is $169. What you pay, from the second month, is $240. Both figures come from the company. Only one of them is on the page making the promise.

We list Palm Beach Labs at $240 a month on our NAD+ price index, because that is the rate a subscriber is on for every month except the first. Anyone comparing a $169 floor against another seller's standing rate is comparing a promotion to a price.

What the guarantee and cancellation terms actually say

The sales site advertises a 60-day guarantee. Its expanded guarantee panel says a buyer can request a refund even after using the vial. The current Terms of Service require more careful reading than a simple no-refund label: their general nonrefundable-fees clause begins “except as otherwise set forth in any return or refund policy provided to you on the services.” That exception matters. A separately supplied guarantee may qualify; the terms do not automatically invalidate it.⁷⁸

The terms themselves describe prorated refunds for treatment a network pharmacy cannot supply, based on the unshipped portion of a prepaid plan, and say approved refunds are processed within 30 days. They do not spell out how the advertised satisfaction guarantee applies to medication, clinician fees, renewals or multiple shipments. Save the guarantee offered with your order and ask customer support which charges it covers before paying.

The sales page says subscriptions can be canceled or paused anytime. The terms qualify cancellation by the cutoff disclosed at purchase. Ask for that cutoff and the cancellation method before the next charge; canceling future shipments is a different question from requesting a refund for an existing order.⁷⁸

The terms identify Buttoned Up Leads LLC as the operator of the main website. They do not expressly name the second storefront that links to them.

What the injection actually is, and what nobody has measured

The sales-site page is not selling energy. It is selling skin.

It is addressed to women over 40 and promises that a prescription NAD+ injection helps with wrinkles, "jowls", "turkey neck", loose and crepey skin, thinning hair and weak nails. It describes an internal mechanism — cellular exhaustion, mitochondrial decline, collagen that stops being rebuilt — and it describes it fluently.

None of it has been demonstrated in a person. There is no published human pharmacokinetic study of subcutaneous NAD+, no randomized trial of it for skin, hair, energy or aging, and no controlled evidence that injecting NAD+ changes how anyone looks. The single human study of administered NAD+ we can point to is a small pilot in which participants received a six-hour intravenous infusion, and it measured the plasma and urine metabolome rather than any clinical outcome.² Injection is not infusion, and even the infusion literature stops there. What the injection evidence actually shows is the long version, and our page on NAD+ for skin covers the dermatological claims specifically.

One claim on that page deserves to be named directly. Under "About NAD+ Injections", the site states: "100% Bioavailability. Zero Waste." That is a precise pharmacokinetic assertion, expressed as a number, about a route for which no pharmacokinetic study in humans exists. It is not a hedge or a marketing adjective; it is a measurement nobody has taken.

The route with controlled human data behind it is the oral precursor, which this company does not sell. Nicotinamide riboside is orally bioavailable and raises blood NAD+ in people,³ reliably over months of dosing,⁴ and in aged human skeletal muscle.⁵ Even there, the benefits downstream of the biomarker are the weak part: a systematic review of precursor trials found metabolic effects limited and inconsistent despite NAD+ rising.⁶ Compounded NAD+ is not an FDA-approved drug for any indication, which is true of every seller in this category rather than this one alone.

The supplement disclaimer on a prescription page

At the very bottom of the sales site, under the phone number, sits this: "These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."

That is the dietary-supplement disclaimer. It is the sentence a bottle of vitamins carries. The product on the page above it is a compounded prescription medication that requires a clinician's evaluation and is shipped by a licensed pharmacy — a different regulatory category with different rules, and one where "not intended to treat any disease" is an odd thing to say about a drug somebody is prescribing you. Whatever it was meant to accomplish, it tells a reader the wrong thing about what they are buying.

What it publishes well

Two things here are better than you usually get from a compounded NAD+ seller.

The pharmacies are named. Palm Beach Labs states that it is not a pharmacy and identifies its current partners: Partell Pharmacy and Strive Pharmacy, each with a website and a contact address published beside it. Naming partners is useful, but it does not confirm the actual facility assigned to an individual prescription. The Pepti review likewise distinguishes its named pharmacy partner from the dispensing details a buyer should confirm.

The clinician network is named, as Beluga Health, with its own contact address published. A medical advisor, Dr. Darshan Shah, is named with his training listed — though the company itself is clear that the clinician who reviews your intake is an independent provider in that network, not him.

Against that: no state list is published, only a terms clause about being located in a state where the company operates. No corporate mailing address appears. And the product card gives the NAD+ Injectable as "100 ml" with no strength attached, while glutathione is "200 ml" and the metformin and sermorelin beside them are given in milligrams. A volume label is not a concentration or total supplied dose, and the card’s meaning needs confirmation. The Auren Rx review also separates the current offer from vial quantities that have not been reconfirmed. Without the actual concentration and supplied volume, a cost-per-milligram comparison is not reliable.

Where it lands

Palm Beach Labs names its pharmacies and its clinician network, which puts it ahead of many sellers on the disclosure that matters most for a compounded drug. That is worth something and we would not want it lost in what follows.

But a buyer arriving from an ad has to get three things right that the company has made harder than they need to be: that $169 is a first month and $240 is the price, that the advertised guarantee needs its scope and claim process confirmed, and that an injection sold for jowls and crepey skin has no human trial behind any of it. Two of those three are only discoverable by reading a second website, or by clicking a tab most buyers will never open.

Ask what a standing month costs, in writing, before you start an intake — and ask whether the 60-day guarantee will be honored, in writing, from the same address. Then ask the prior question, which no price on either site answers. The cheapest way to raise NAD+ on evidence that exists is still an oral precursor, at a fraction of any figure here: is NAD+ therapy worth it, is nicotinamide riboside worth it and NMN vs NR work through it. More providers are compared on our NAD+ rankings hub.